Meta-Analysis of Atrial Fibrillation Ablation in Patients with Systolic Heart Failure

Table 5

Complications related to catheter ablation.

	Khan; (N = 41)	MacDonald; (N = 21)	Jones; (N = 25)	Hunter; (N = 26)	Di Biase; (N = 102)	Prabhu; (N = 33)	Marrouch; (N = 151)	Total; (N=399)
Death, N ()	0; (0.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)
Stroke, N ()	0; (0.0%)	1; (4.8%)	0; (0.0%)	1; (3.8%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	2; (0.5%)
Cardiac tamponade, N ()	0; (0.0%)	2; (9.5%)	1; (4.0%)	1; (3.8%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	4; (1.0%)
Pericardial effusion, N ()	1; (2.4%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	1; (1.0%)	0; (0.0%)	3; (2.0%)	5; (1.3%)
Pulmonary vein stenosis, N ()	2; (4.9%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	1; (0.7%)	3 (0.8%)
Access site complications, N ()	3; (7.3%)	0; (0.0%)	1; (4.0%)	0; (0.0%)	2; (2.0%)	1; (3.0%)	6; (4.0%)	13; (3.3%)
Heart failure exacerbation, N ()	1; (2.4%)	3; (14.3%)	1; (4.0%)	0; (0.0%)	0; (0.0%)	0; (0.0%)	1; (0.7%)	6; (1.5%)